The present invention relates to ready-to-drink cocoa milk beverage products. In particular, the invention is concerned with a protein system induced by controlled aggregation of milk proteins which imparts outstanding sensory attributes and improved physical stability of the beverage products, in particular when containing low fat and/or low sugar. A method of 5 producing such beverage and the products obtainable from the method are also part of the present invention.

The present invention discloses palatable oral formulations for hydrating, supporting gut activity, micronutrient supplementation and providing oral carriers for vaccines, antibiotics and food supplements, of inter alia, companion or pet animals.

The present invention discloses palatable oral formulations for hydrating, supporting gut activity, micronutrient supplementation and providing oral carriers for vaccines, antibiotics and food supplements, of inter alia, companion or pet animals.

A zero-sugar beverage composition is provided that includes an electrolyte, acid, and nonnutritive sweeteners. The electrolyte blend used in the beverage has a high buffering capacity, which enables an increased amount of citric acid to be added while maintaining a pH of about 3.4. The combination of sweeteners sucralose and acesulfame potassium, electrolyte blend having high buffering capacity, citric acid, and a variety of flavoring systems provides a beverage that is well accepted by consumers.

A zero-sugar beverage composition is provided that includes an electrolyte, acid, and nonnutritive sweeteners. The electrolyte blend used in the beverage has a high buffering capacity, which enables an increased amount of citric acid to be added while maintaining a pH of about 3.4. The combination of sweeteners sucralose and acesulfame potassium, electrolyte blend having high buffering capacity, citric acid, and a variety of flavoring systems provides a beverage that is well accepted by consumers.

An aerated food product includes a base ingredient, a protein and a liquid and, in some instances, a carbohydrate source. The base ingredient may include a whole grain source, a fiber source, a fruit source, a vegetable source, or a combination thereof. In some aspects, the product has a moisture content in the range of about 1% to about 5%. In one embodiment, the product has a density in the range of about 0.02 g/cc to about 0.50 g/cc. In some embodiments the product has a porosity in the range of about 15% to about 65%. In some embodiments, the product has a texture hardness in the range of about 1 kg to about 7 kg.

An aerated food product includes a base ingredient, a protein and a liquid and, in some instances, a carbohydrate source. The base ingredient may include a whole grain source, a fiber source, a fruit source, a vegetable source, or a combination thereof. In some aspects, the product has a moisture content in the range of about 1% to about 5%. In one embodiment, the product has a density in the range of about 0.02 g/cc to about 0.50 g/cc. In some embodiments the product has a porosity in the range of about 15% to about 65%. In some embodiments, the product has a texture hardness in the range of about 1 kg to about 7 kg.

A system and method to control the nucleation of gas from supersaturated liquids is disclosed. In some embodiments, the system and method is used to control the nucleation of carbonated bodies when combined with additive bodies that may cause an undesirable amount of nucleation. In some embodiments, the system and method is used to control the foam created when adding cocktail mixers to carbonated liquids such as beer and other types of carbonated beverages.

A system and method to control the nucleation of gas from supersaturated liquids is disclosed. In some embodiments, the system and method is used to control the nucleation of carbonated bodies when combined with additive bodies that may cause an undesirable amount of nucleation. In some embodiments, the system and method is used to control the foam created when adding cocktail mixers to carbonated liquids such as beer and other types of carbonated beverages.

Choline alfoscerate is a drug used to improve cerebrovascular diseases and brain metabolism. It is a drug with proven safety, which has no effect on the kidney and liver and with no severe side effect reported. When administered to a patient with muscle cramps, it can significantly reduce pain and the occurrence of muscle cramps. Accordingly, it may be used as an active ingredient in a pharmaceutical composition for treating or preventing muscle cramps and a health functional food composition for improving muscle cramps and may also be used for a method for treating muscle cramps by administering choline alfoscerate. In addition, choline alfoscerate may also be used to prepare a medication for treating muscle cramps.